{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:55:49Z","timestamp":1776308149151,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cardfail.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:51:41Z","timestamp":1549911101000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9194-5330","authenticated-orcid":false,"given":"Jonathan H,","family":"Soslow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Slaughter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Crum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-5330","authenticated-orcid":false,"given":"W. Bryan","family":"Burnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Ru","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Tomasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry W.","family":"Markham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2019.02.006_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0009922809347777","article-title":"Duchenne muscular dystrophy: a 30-year population-based incidence study","volume":"49","author":"Dooley","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4187\/respcare.00831","article-title":"Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival","volume":"56","author":"Bach","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0003","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00246-001-0040-0","article-title":"Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy","volume":"23","author":"Mori","year":"2002","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijcard.2006.07.163","article-title":"B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy","volume":"119","author":"Mohyuddin","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0006","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years\u2019 follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0007","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet neurology"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1532-429X-13-60","article-title":"Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance","volume":"13","author":"Hor","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0046-8177(76)80053-6","article-title":"The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis","volume":"7","author":"Frankel","year":"1976","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12968-016-0224-7","article-title":"Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy","volume":"18","author":"Soslow","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","author":"Passino","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.cardfail.2019.02.006_bib0014","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00246-017-1793-4","article-title":"Effect of weight extremes on ventricular volumes and myocardial strain in repaired tetralogy of Fallot as measured by CMR","volume":"39","author":"Simpson","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00246-014-0929-z","article-title":"Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy","volume":"35","author":"Menon","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0017","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.apmr.2010.03.024","article-title":"Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy","volume":"91","author":"Mathur","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0018","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-12-91","article-title":"Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures","volume":"12","author":"Lerario","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0019","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.24346","article-title":"Outcome reliability in nonambulatory boys\/men with Duchenne muscular dystrophy","volume":"51","author":"Connolly","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JND-150132","article-title":"The correlation of skeletal and cardiac muscle dysfunction in Duchenne muscular dystrophy","volume":"3","author":"Posner","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0022","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00246-017-1703-9","article-title":"Interleukin 1 receptor\u2013like 1 protein (ST2) is a potential biomarker for cardiomyopathy in Duchenne muscular dystrophy","volume":"38","author":"Anderson","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0023","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/pr.2015.257","article-title":"Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac\/skeletal muscle function in Duchenne muscular dystrophy","volume":"79","author":"Galindo","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0024","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FJC.0b013e31821823d9","article-title":"Biomarkers of myocardial fibrosis","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0025","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/jcp.25430","article-title":"Intricate functions of matrix metalloproteinases in physiological and pathological conditions","volume":"231","author":"Mittal","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.pmbts.2017.01.001","article-title":"The balance between metalloproteinases and TIMPs: critical regulator of microvascular endothelial cell function in health and disease","volume":"147","author":"Masciantonio","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0027","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00441-009-0889-4","article-title":"Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment","volume":"339","author":"Zanotti","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0028","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcell.2014.00011","article-title":"Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy","volume":"2","author":"Ogura","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0029","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/CIRCULATIONAHA.106.612960","article-title":"Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction","volume":"113","author":"Lindsey","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0031","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2006.01.077","article-title":"Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure","volume":"48","author":"Lopez","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/S1388-9842(02)00092-2","article-title":"Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy","volume":"4","author":"Schwartzkopff","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0033","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0034","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nmd.2015.01.010","article-title":"Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy","volume":"25","author":"Zocevic","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0036","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","article-title":"All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy","volume":"61","author":"Schram","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0037","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0038","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2353\/ajpath.2010.091176","article-title":"Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice","volume":"177","author":"Kumar","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0039","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mus.23331","article-title":"Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice","volume":"46","author":"Pereira","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cardfail.2019.02.006_bib0041","article-title":"Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix metalloproteinase-9 inhibitor andecaliximab in patients with rheumatoid arthritis","author":"Gossage","year":"2017","journal-title":"Clin Ther"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916419301575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916419301575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:42:23Z","timestamp":1761028943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916419301575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1071916419301575"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2019.02.006","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}